An urgent investigation into the matter was immediately launched by the UK Government.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The UK Health Security Agency has announced that it has recently detected higher than usual rates of liver inflammation (hepatitis) among children, but has ruled out the common viruses that cause hepatitis so have therefore launched an urgent investigation.
The terrible news shocked the public, after Pfizer released its brand new study, suggesting the rise of hepatitis among the youngest and most fragile population was due to the COVID shot.
The UK Health Security Agency (UKHSA) has recently detected higher than usual rates of liver inflammation (hepatitis) in children. Similar cases are also being assessed in Scotland.
“Hepatitis is a condition that affects the liver and may occur for a number of reasons, including several viral infections common in children. However, in the cases under investigation the common viruses that cause hepatitis have not been detected.”
Hepatitis symptoms include:
– dark urine
– pale, grey-colored poo
– itchy skin
– yellowing of the eyes and skin (jaundice)
– muscle and joint pain
– a high temperature
– feeling and being sick
– feeling unusually tired all the time
– loss of appetite
– tummy pain
“UKHSA is allegedly working swiftly with the NHS and public health colleagues across the UK to investigate the potential cause. But it would appear they need not look any further than the experimental Pfizer Covid-19 injection they have outrageously been giving to children. Because Pfizer’s own study confirms the mRNA jab accumulates in the liver causing hepatitis,” The Expose wrote.
““The greatest mean concentration outside the injection site was observed in the liver, with values of 27.916 μg equiv lipid/g (equivalent to 21.5 % dose) in males and 30.411 μg equiv lipid/g (equivalent to 18.4 % dose) in females.”
The Japanese regulatory agency’s bio-distribution study of the Pfizer vaccine shows that the contents of the Covid-19 injection travels from the injection site, through the bloodstream, and ends up in various organs such as the liver, spleen, adrenal glands, and ovaries for at least 48 hours after injection.
“In animals that received the BNT162b2 injection, reversible hepatic effects were observed, including enlarged liver, vacuolation, increased gamma-glutamyl transferase (γGT) levels, and increased levels of aspartate transaminase (AST) and alkaline phosphatase (ALP)”
According to the researchers’ transient hepatic effects induced by LNP delivery systems have been reported previously.”